2024
W35 Nicotine Use and Metabotropic Glutamate Receptor 5 (mGluR5) in Individuals With Major Depressive and Post Traumatic Stress Disorders
Baldassarri S, Asch R, Hillmer A, Pietrzak R, DellaGioia N, Esterlis I, Davis M. W35 Nicotine Use and Metabotropic Glutamate Receptor 5 (mGluR5) in Individuals With Major Depressive and Post Traumatic Stress Disorders. Drug And Alcohol Dependence 2024, 260: 110653. DOI: 10.1016/j.drugalcdep.2023.110653.Peer-Reviewed Original Research
2019
Lower synaptic density is associated with depression severity and network alterations
Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I. Lower synaptic density is associated with depression severity and network alterations. Nature Communications 2019, 10: 1529. PMID: 30948709, PMCID: PMC6449365, DOI: 10.1038/s41467-019-09562-7.Peer-Reviewed Original ResearchConceptsMajor depressive disorderPost-traumatic stress disorderLower synaptic densitySynaptic densityPositron emission tomographyFunctional connectivityNetwork alterationsSynaptic vesicle glycoprotein 2ASymptoms of depressionSynaptic lossDepressive disorderHealthy controlsNerve terminalsDepressive symptomsDepression severityUnmedicated individualsSynaptic connectionsEmission tomographyStress disorderVivo evidenceSymptomsDepressionSeverityDisordersAlterations
2017
Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence
Holmes SE, Girgenti MJ, Davis MT, Pietrzak RH, DellaGioia N, Nabulsi N, Matuskey D, Southwick S, Duman RS, Carson RE, Krystal JH, Esterlis I, Friedman M, Kowall N, Brady C, McKee A, Stein T, Huber B, Kaloupek D, Alvarez V, Benedek D, Ursano R, Williamson D, Cruz D, Young K, Duman R, Krystal J, Mash D, Hardegree M, Serlin G. Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence. Proceedings Of The National Academy Of Sciences Of The United States Of America 2017, 114: 8390-8395. PMID: 28716937, PMCID: PMC5547601, DOI: 10.1073/pnas.1701749114.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderMGluR5 availabilityPositron emission tomographyGlutamate systemMetabotropic glutamate receptor 5Treatment of PTSDHuman posttraumatic stress disorderGlutamate receptor 5Mechanism-based treatmentsExpression of FKBP5Promising treatment targetHuman postmortem tissueTargeted pharmacological treatmentStress psychopathologyPharmacological treatmentExpression of proteinsReceptor 5MGluR5Treatment targetsPostmortem tissueEmission tomographyStress disorderPostmortem samplesPromising targetDisorders
2014
PTSD Symptom Clusters Are Differentially Associated with Components of the Acquired Capability for Suicide
Zuromski KL, Davis MT, Witte TK, Weathers F, Blevins C. PTSD Symptom Clusters Are Differentially Associated with Components of the Acquired Capability for Suicide. Suicide And Life-Threatening Behavior 2014, 44: 682-697. PMID: 24796870, DOI: 10.1111/sltb.12098.Peer-Reviewed Original ResearchConceptsPTSD symptom clustersPosttraumatic stress disorderAcquired CapabilitySpecific PTSD symptom clustersSymptom clustersTrauma-exposed undergraduatesInterpersonal-psychological theorySuicidal behaviorAnxious arousalPTSD symptomsStress disorderPain tolerancePrevious researchCurrent studySuicideNumbingObserved relationshipArousalRelationshipUndergraduatesConstructsBehaviorDisordersResearchSymptoms
2009
Sex Differences in Effectiveness of Extended-Release Stimulant Medication among Adolescents with Attention-Deficit/Hyperactivity Disorder
Mikami AY, Cox DJ, Davis MT, Wilson HK, Merkel RL, Burket R. Sex Differences in Effectiveness of Extended-Release Stimulant Medication among Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal Of Clinical Psychology In Medical Settings 2009, 16: 233-242. PMID: 19418208, DOI: 10.1007/s10880-009-9165-8.Peer-Reviewed Original ResearchConceptsAttention-deficit/hyperactivity disorderStimulant medicationHyperactivity disorderFemale adolescentsADHD symptom ratingsOsmotic-release methylphenidateNeuropsychological tasksParent reportAmphetamine saltsAdolescent femalesAdolescent populationSymptom ratingsAdolescentsObjective measuresSex differencesDouble-blind crossover studyMedication regimenCrossover studyMedication efficacyImpulsivityInattentionDisordersMedicationsSide effectsMethylphenidate